How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Multiple Myeloma Trials

Select Clinical Trial

Protocol Number: ECOG E1A11

Protocol Title: Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Eligibility: Men or women, 18 years or older, newly diagnosed with standard risk, multiple myeloma.

Contact Information: (910) 715-2200


Protocol Number: Amgen Kyprolis

Protocol Title: An Open-label Phase 2 Study of Carfilzomib Plus Dexamethasone To Assess Tolerability and Adherence in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers

Eligibility: Men or women, ages 18 and older with relapsed or refractory Multiple Myeloma

Contact Information: (910) 715-2200

Clara McLean House
Make a Donation
News & Events